Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RxSight (RXST) Retained Earnings (2020 - 2025)

RxSight (RXST) has disclosed Retained Earnings for 6 consecutive years, with -$661.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Retained Earnings fell 398316.27% year-over-year to -$661.0 million, compared with a TTM value of -$661.0 million through Dec 2025, down 398316.27%, and an annual FY2025 reading of -$661.0 million, down 398316.27% over the prior year.
  • Retained Earnings was -$661.0 million for Q4 2025 at RxSight, down from -$651.9 million in the prior quarter.
  • Across five years, Retained Earnings topped out at $166000.0 in Q4 2024 and bottomed at -$661.0 million in Q4 2025.
  • Average Retained Earnings over 5 years is -$239.2 million, with a median of -$118000.0 recorded in 2024.
  • The sharpest move saw Retained Earnings crashed 1026828.33% in 2024, then soared 128.3% in 2025.
  • Year by year, Retained Earnings stood at -$20000.0 in 2021, then plummeted by 375.0% to -$95000.0 in 2022, then tumbled by 625836.84% to -$594.6 million in 2023, then soared by 100.03% to $166000.0 in 2024, then tumbled by 398316.27% to -$661.0 million in 2025.
  • Business Quant data shows Retained Earnings for RXST at -$661.0 million in Q4 2025, -$651.9 million in Q3 2025, and -$117000.0 in Q2 2025.